UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

073 - Regional Differences during Acute Heart Failure Hospitalizations of Patients with Heart Failure with Preserved Ejection Fraction: Insights From ASCEND-HF

Journal of cardiac failure, 2016-08, Vol.22 (8), p.S27-S27

2016

Volltextzugriff (PDF)

1.1.15 The Thermal Emission of the Dust Corona During the Eclipse of June 30, 1975

International Astronomical Union Colloquium, 1976, Vol.31, p.67-67

1976

Volltextzugriff (PDF)

1-(1,2,5-Thiadiazol-4-yl)-4-azatricyclo[2.2.1.0 2,6 ]heptanes as New Potent Muscarinic M 1 Agonists: Structure−Activity Relationship for 3-Aryl-2-propyn-1-yloxy and 3-Aryl-2-propyn-1-ylthio Derivatives

Journal of medicinal chemistry, 1999-06, Vol.42 (11), p.1999-2006

1999

Volltextzugriff (PDF)

1-(1,2,5-Thiadiazol-4-yl)-4-azatricyclo[2.2.1.02,6]heptanes as New Potent Muscarinic M1 Agonists: Structure−Activity Relationship for 3-Aryl-2-propyn-1-yloxy and 3-Aryl-2-propyn-1-ylthio Derivatives

Journal of medicinal chemistry, 1999-06, Vol.42 (11), p.1999-2006

1999

Volltextzugriff (PDF)

1+1 Dedicated Optical-Layer Protection Strategy for Filterless Optical Networks

IEEE communications letters, 2014-01, Vol.18 (1), p.98-101

2014

Volltextzugriff (PDF)

1,25-(OH)2-vitamin D3 prevents activation of hepatic stellate cells in vitro and ameliorates inflammatory liver damage but not fibrosis in the Abcb4−/− model

Biochemical and biophysical research communications, 2015-04, Vol.459 (2), p.227-233

2015

Volltextzugriff (PDF)

1,25-(OH){sub 2}-vitamin D{sub 3} prevents activation of hepatic stellate cells in vitro and ameliorates inflammatory liver damage but not fibrosis in the Abcb4{sup −/−} model

Biochemical and biophysical research communications, 2015-04, Vol.459 (2)

2015

Volltextzugriff (PDF)

1,3-Dicyclohexyl urea nanosuspension for intravenous steady-state delivery in rats

Journal of experimental nanoscience, 2007-09, Vol.2 (3), p.239-250

2007

Volltextzugriff (PDF)

1-{(E)-[5-(2-Nitro-phen-yl)furan-2-yl]methyl-idene}-2,2-diphenyl-hydrazine

Acta crystallographica. Section E, Structure reports online, 2013-01, Vol.69 (Pt 1), p.o90-o90

2013

Volltextzugriff (PDF)

1-{( E )-[5-(2-Nitrophenyl)furan-2-yl]methylidene}-2,2-diphenylhydrazine

Acta crystallographica. Section E, Structure reports online, 2013-01, Vol.69 (1), p.o90-o90

2013

Volltextzugriff (PDF)

10 Be data from meltwater channels suggest that Jameson Land, east Greenland, was ice-covered during the last glacial maximum

Quaternary research, 2011-11, Vol.76 (3), p.452-459

2011

Volltextzugriff (PDF)

1021: REAL-TIME MONITORING OF THE PATIENT EXPERIENCE DURING NEOADJUVANT THERAPY FOR GASTROINTESTINAL CANCER USING A CUSTOMIZED SMARTPHONE APPLICATION: PROOF OF FEASIBILITY

Gastroenterology (New York, N.Y. 1943), 2022-05, Vol.162 (7), p.S-1354

2022

Volltextzugriff (PDF)

1050P Association of ctDNA quantification with prognosis and early prediction of response to first-line osimertinib in NSCLC patients

Annals of oncology, 2022-09, Vol.33, p.S1035

2022

Volltextzugriff (PDF)

10Be data from meltwater channels suggest that Jameson Land, east Greenland, was ice-covered during the last glacial maximum

Quaternary research, 2011-11, Vol.76 (3), p.452-459

2011

Volltextzugriff (PDF)

1121P Real-world (RW) data from the sotorasib French pre-market authorization early access program in patients (pts) with KRASG12C driven metastatic non-small cell lung cancer (mNSCLC): Clinical characteristics

Annals of oncology, 2022-09, Vol.33, p.S1063-S1064

2022

Volltextzugriff (PDF)

114-nm wavelength tuning range of a vertical grating assisted codirectional coupler laser with a super structure grating distributed bragg reflector

IEEE photonics technology letters, 1995-07, Vol.7 (7), p.697-699

1995

Volltextzugriff (PDF)

1173P Early safety, tolerability, and efficacy of REGN5093 in patients (pts) with MET-altered advanced non-small cell lung cancer (aNSCLC) from a first in human (FIH) study

Annals of oncology, 2022-09, Vol.33, p.S1085

2022

Volltextzugriff (PDF)

1235PCILENGITIDE (CIL) COMBINED WITH CETUXIMAB AND PLATINUM-BASED CHEMOTHERAPY AS FIRST-LINE TREATMENT IN ADVANCED NON-SMALL CELL LUNG CANCER (NSCLC) PATIENTS (PTS): PHASE II RANDOMISED CERTO STUDY

Annals of oncology, 2014-09, Vol.25 (suppl_4), p.iv432-iv432

2014

Volltextzugriff (PDF)

1264 ANALYSIS OF INTERSTITIAL CELLS OF CAJAL IN GASTROPARESIS PATIENTS WITH DIFFERENT ETIOLOGIES VERSUS AUTOSPY SAMPLES FROM INDIVIDUALS WITHOUT GATSROPARESIS

Gastroenterology (New York, N.Y. 1943), 2024-05, Vol.166 (5), p.S-299-S-299

2024

Volltextzugriff (PDF)

1288. Evaluation of Predictors for Clinical Success in Patients Treated with Eravacycline for Various Infections

Open forum infectious diseases, 2021-12, Vol.8 (Supplement_1), p.S733-S733

2021

Volltextzugriff (PDF)

1298PCRIZOTINIB IN PATIENTS WITH LUNG CANCER AND ROS1 FUSION: RESULTS FROM THE EUROPEAN COHORT EUROS1

Annals of oncology, 2014-09, Vol.25 (suppl_4), p.iv457-iv458

2014

Volltextzugriff (PDF)

1306P Platin pemetrexed with or without bevacizumab with upfront versus “at progression” brain radiotherapy in advanced non squamous non-small cell lung cancer with asymptomatic brain metastasis: A randomized phase III trial (Metal2 trial)

Annals of oncology, 2020-09, Vol.31, p.S845-S845

2020

Volltextzugriff (PDF)

1359P Relationship between tumor TP53 gene mutation, circulating anti-p53 antibodies and response to first-line osimertinib in EGFR-mutated NSCLC patients

Annals of oncology, 2023-10, Vol.34, p.S781-S781

2023

Volltextzugriff (PDF)

137O Nivolumab in patients (pts) with advanced refractory squamous (SQ) non-small cell lung cancer (NSCLC): 2-year follow-up from CheckMate 063 and exploratory cytokine profiling analyses

Journal of thoracic oncology, 2016-04, Vol.11 (4), p.S115-S116

2016

Volltextzugriff (PDF)

137O: Nivolumab in patients (pts) with advanced refractory squamous (SQ) non-small cell lung cancer (NSCLC): 2-year follow-up from CheckMate 063 and exploratory cytokine profling analyses

Journal of thoracic oncology, 2016-04, Vol.11 (4 Suppl), p.S115-S116

2016

Volltextzugriff (PDF)

1 – 25 von 3.898

Suche als RSS-Feed

Aktive Filter

ThemaAdult

ThemaMedicin Och Hälsovetenskap

ThemaNeurosciences & Neurology

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(3.326)
Mit Volltextzugriff
(3.288)

Publikationsform

6 weitere anzeigen...

Weniger anzeigen...

Sprache

10 weitere anzeigen...

Weniger anzeigen...

Erscheinungsjahr

n.n

Thema

Science & Technology
(2.366)
Life Sciences & Biomedicine
(1.678)
Humans
(956)
Animals
(526)
Biological And Medical Sciences
(463)
Physical Sciences
(451)
Male
(385)
Female
(382)
Technology
(354)
Medical Sciences
(269)
Mice
(218)
Fundamental And Applied Biological Sciences. Psychology
(216)
Biochemistry & Molecular Biology
(215)
Science & Technology - Other Topics
(187)
Engineering
(164)
Multidisciplinary Sciences
(151)
Physics
(147)
Computer Science
(146)
Chemistry
(138)
Aged
(129)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

Menü

Weitere Dienste

Einstellungen

073 - Regional Differences during Acute Heart Failure Hospitalizations of Patients with Heart Failure with Preserved Ejection Fraction: Insights From ASCEND-HF

1.1.15 The Thermal Emission of the Dust Corona During the Eclipse of June 30, 1975

1-(1,2,5-Thiadiazol-4-yl)-4-azatricyclo[2.2.1.0 2,6 ]heptanes as New Potent Muscarinic M 1 Agonists: Structure−Activity Relationship for 3-Aryl-2-propyn-1-yloxy and 3-Aryl-2-propyn-1-ylthio Derivatives

1-(1,2,5-Thiadiazol-4-yl)-4-azatricyclo[2.2.1.02,6]heptanes as New Potent Muscarinic M1 Agonists: Structure−Activity Relationship for 3-Aryl-2-propyn-1-yloxy and 3-Aryl-2-propyn-1-ylthio Derivatives

1+1 Dedicated Optical-Layer Protection Strategy for Filterless Optical Networks

1,25-(OH)2-vitamin D3 prevents activation of hepatic stellate cells in vitro and ameliorates inflammatory liver damage but not fibrosis in the Abcb4−/− model

1,25-(OH){sub 2}-vitamin D{sub 3} prevents activation of hepatic stellate cells in vitro and ameliorates inflammatory liver damage but not fibrosis in the Abcb4{sup −/−} model

1,3-Dicyclohexyl urea nanosuspension for intravenous steady-state delivery in rats

1-{(E)-[5-(2-Nitro-phen-yl)furan-2-yl]methyl-idene}-2,2-diphenyl-hydrazine

1-{( E )-[5-(2-Nitrophenyl)furan-2-yl]methylidene}-2,2-diphenylhydrazine

10 Be data from meltwater channels suggest that Jameson Land, east Greenland, was ice-covered during the last glacial maximum

1021: REAL-TIME MONITORING OF THE PATIENT EXPERIENCE DURING NEOADJUVANT THERAPY FOR GASTROINTESTINAL CANCER USING A CUSTOMIZED SMARTPHONE APPLICATION: PROOF OF FEASIBILITY

1050P Association of ctDNA quantification with prognosis and early prediction of response to first-line osimertinib in NSCLC patients

10Be data from meltwater channels suggest that Jameson Land, east Greenland, was ice-covered during the last glacial maximum

1121P Real-world (RW) data from the sotorasib French pre-market authorization early access program in patients (pts) with KRASG12C driven metastatic non-small cell lung cancer (mNSCLC): Clinical characteristics

114-nm wavelength tuning range of a vertical grating assisted codirectional coupler laser with a super structure grating distributed bragg reflector

1173P Early safety, tolerability, and efficacy of REGN5093 in patients (pts) with MET-altered advanced non-small cell lung cancer (aNSCLC) from a first in human (FIH) study

1235PCILENGITIDE (CIL) COMBINED WITH CETUXIMAB AND PLATINUM-BASED CHEMOTHERAPY AS FIRST-LINE TREATMENT IN ADVANCED NON-SMALL CELL LUNG CANCER (NSCLC) PATIENTS (PTS): PHASE II RANDOMISED CERTO STUDY

1264 ANALYSIS OF INTERSTITIAL CELLS OF CAJAL IN GASTROPARESIS PATIENTS WITH DIFFERENT ETIOLOGIES VERSUS AUTOSPY SAMPLES FROM INDIVIDUALS WITHOUT GATSROPARESIS

1288. Evaluation of Predictors for Clinical Success in Patients Treated with Eravacycline for Various Infections

1298PCRIZOTINIB IN PATIENTS WITH LUNG CANCER AND ROS1 FUSION: RESULTS FROM THE EUROPEAN COHORT EUROS1

1306P Platin pemetrexed with or without bevacizumab with upfront versus “at progression” brain radiotherapy in advanced non squamous non-small cell lung cancer with asymptomatic brain metastasis: A randomized phase III trial (Metal2 trial)

1359P Relationship between tumor TP53 gene mutation, circulating anti-p53 antibodies and response to first-line osimertinib in EGFR-mutated NSCLC patients

137O Nivolumab in patients (pts) with advanced refractory squamous (SQ) non-small cell lung cancer (NSCLC): 2-year follow-up from CheckMate 063 and exploratory cytokine profiling analyses

137O: Nivolumab in patients (pts) with advanced refractory squamous (SQ) non-small cell lung cancer (NSCLC): 2-year follow-up from CheckMate 063 and exploratory cytokine profling analyses

Aktive Filter

Suchergebnisse filtern